NCT04943627 2022-10-05Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)Agenus Inc.Phase 3 Withdrawn
NCT02348398 2016-08-16Phase II Study of Pazopanib and Topotecan in Cervical CancerM.D. Anderson Cancer CenterPhase 2 Withdrawn